Serious Risks or Adverse Reactions While BPC-157 has not been associated with serious or life-threatening complications in animal research, it's still important to consider the potential risks especially due to the lack of human clinical trials and regulation in the peptide marketplace
Some payers limit how many times it can be billed in a single day
How does a monthly payment differ from an annual payment
Injection Site : Different sites may require different needle lengths and gauges to promote the correct and comfortable delivery of the medication

In addition, included were, i.e., 4-week intravenous toxicity in rats followed by 4 weeks of recovery, 4-week intravenous toxicity in dogs, sub-acute (14 days) intracolonic toxicity study in rats and Beagle dogs, a repeated dose (28 days) dermal toxicity study in Wistar rats, chromosome aberrations in human lymphocytes cultured in vitro, an Ames test, a micronucleus test, female fertility and early embryonal development after intravenous administration to rats, embryofetal development after intravenous administration to rats (including toxicokinetics in pregnant animals and placental transfer), embryofetal development after intravenous administration in New Zealand White rabbits, cardiovascular and respiratory systems in anesthetized dog, a sensitization study in guinea pigs (Maximization test), and an acute eye irritation/corrosion study in albino rabbits